K041003 is an FDA 510(k) clearance for the IMMUNOCARD TOXINS A & B, MODEL 712050. Classified as Reagents, Clostridium Difficile Toxin (product code LLH), Class I - General Controls.
Submitted by Meridian Bioscience, Inc. (Cincinnati, US). The FDA issued a Cleared decision on August 20, 2004 after a review of 123 days - within the typical 510(k) review window.
This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.2660 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.
View all Meridian Bioscience, Inc. devices